跳至主要内容
临床试验/NCT04371159
NCT04371159已完成不适用

A Comparative, Controlled Study to Evaluate the Clinical Accuracy of the Velieve U.S. UTI Urine Analysis Test System

Healthy.io Ltd.1 个研究点 分布在 1 个国家目标入组 125 人开始时间: 2020年2月5日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
125
试验地点
1
主要终点
Evaluation of the % agreement of the Velieve U.S., tested by the lay user, as compared to a comparator device, tested by a professional user.

研究概览

简要总结

The Velieve U.S. UTI Urine Analysis Test System (henceforth Velieve U.S.) is composed of a kit and a smartphone application. The device will be provided to the subject in a simulated home-use environment. All subjects will be asked to complete the urine test by following the application guidance,including providing a urine sample and scanning the urine strip after placing it on the Color-Board. The user will also complete a questionnaire to collect information regarding the use of the Velieve U.S. device. Following the usability test performed by the lay user, the subject's urine sample will be tested by the professional user using the comparator device.

The use of the Velieve U.S. device will be evaluated for identified risks. Additionally, measurable usability criteria for specific, critical steps will be evaluated.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Males and Females 18-80 years of age;
  • •Subjects who are healthy or:
  • •Subjects with a medical condition that normally present with an abnormal concentration of Leukocytes, Nitrites and Blood: (examples of such conditions include the following):
  • •Urinary tract infection (UTI)
  • •Patients with suspected or known occult blood in urine
  • •Pregnant women
  • •Other relevant conditions
  • •Subjects with any pathological findings which might be identified by the urine test (according to the physician discretion)
  • •Subject is capable and willing to provide informed consent;
  • •Subject has facility with both hands;
  • •Subject is capable and willing to adhere to the study procedures.
  • •Subject is familiar with the use of a smartphone
  • •Subject is capable of comprehending and following instructions in English

排除标准

  • •Subject has dementia.
  • •Subject has mental disorders.
  • •Subject cannot collect urine in a receptacle.
  • •Subject is visually impaired (cannot read the user manual).
  • •Any additional reason the study physician believes disqualifies the subject from participating in the study.

研究组 & 干预措施

Velieve U.S.

Experimental

Each participant will test their urine sample using the Velieve U.S. device

干预措施: Velieve U.S. (Device)

结局指标

主要结局

Evaluation of the % agreement of the Velieve U.S., tested by the lay user, as compared to a comparator device, tested by a professional user.

时间窗: 11 months

次要结局

  • Evaluation of the Velieve U.S. usability success rate, by potential lay users under actual use conditions.(11 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验